Education
About Us
Working with TipRanks
Follow Us
Microbot Medical (MBOT)
:MBOT
MBOT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.82 - $3.94
Previous CloseN/A
Volume6.51M
Average Volume (3M)2.49M
Market Cap
$175.35M
Enterprise Value$0.00
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding45,545,940
10 Day Avg. Volume2,916,709
30 Day Avg. Volume2,486,274
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.00Price Target Upside133.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Clinical Trial SuccessLIBERTY achieves 100% robotic navigation success in the pivotal trial, demonstrating feasibility and a significant reduction in radiation exposure, which supports the case for FDA clearance.
Financial PositionMicrobot Medical raised approximately $13.3M in gross proceeds, enhancing its financial position and supporting future operations.
Intellectual PropertyThe United States Patent and Trademark Office has granted a patent for the LIBERTY endovascular robotic system, which could significantly expand the company's intellectual property portfolio and market reach.
Market PotentialLIBERTY targets more than two million peripheral vascular procedures performed in the U.S. each year, suggesting a large potential market.
Bears Say
Commercial Uptake ChallengesSlower than anticipated future commercial uptake could impact the company's growth and market share.
Regulatory Approval RisksRisks include failure to secure regulatory approval for LIBERTY and slower than anticipated future commercial uptake.
Microbot Medical News
MBOT FAQ
What was Microbot Medical’s price range in the past 12 months?
Microbot Medical lowest stock price was $0.82 and its highest was $3.94 in the past 12 months.
What is Microbot Medical’s market cap?
Microbot Medical’s market cap is $175.35M.
When is Microbot Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Microbot Medical’s earnings last quarter?
Currently, no data Available
Is Microbot Medical overvalued?
According to Wall Street analysts Microbot Medical’s price is currently Undervalued.
Does Microbot Medical pay dividends?
Microbot Medical does not currently pay dividends.
What is Microbot Medical’s EPS estimate?
Microbot Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbot Medical have?
Microbot Medical has 45,545,940 shares outstanding.
What happened to Microbot Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Microbot Medical?
Currently, no hedge funds are holding shares in MBOT
Microbot Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (133.77% Upside)
$9.00 (133.77% Upside)
Crowd Wisdom
Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
294.87%
12-Months-Change
Fundamentals
Return on Equity
-69.80%
Trailing 12-Months
Asset Growth
345.67%
Trailing 12-Months
Company Description
Microbot Medical
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Microbot Medical (MBOT) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
MBOT Stock 12 Month Forecast
Average Price Target
$9.00
▲(133.77% Upside)
Technical Analysis
Ownership Overview
0.30%
Insiders
2.28% Mutual Funds
0.86% Other Institutional Investors
91.92% Public Companies and
Individual Investors